Diet-induced obesity and mammary tumor development in relation to estrogen receptor status

Cancer Letters

Volumn 253, Issue 2, 2007, Pages 291-300

  Ray, Amitabha ^a   Nkhata, Katai J ^a   Grande, Joseph P ^b   Cleary, Margot P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Breast; Cancer; Diet induced obesity; Estrogen receptor; High Fat diet; IGF I; Leptin; Tumors

Indexed keywords

CYCLIN D1; CYCLINE; ESTROGEN RECEPTOR; LEPTIN; PROTEIN BAX; PROTEIN BCL 2; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; HUMAN; HUMAN CELL; LIPID DIET; MOUSE; NONHUMAN; NUDE MOUSE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; DIET; DIETARY FATS; FEMALE; HUMANS; LEPTIN; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; OBESITY; PROTEINS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

MUS; STEATOMYS PRATENSIS;

EID: 34347355253     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.02.005     Document Type: Article

References (50)

1. Shibuya K., Mathers C.D., Boschi-Pinto C., Lopez A.D., and Murray C.J. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2 (2002) 37
2. Shibuya K., Mathers C.D., Boschi-Pinto C., Lopez A.D., and Murray C.J.L. Correction: global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 3 (2003) 20-25
3. Li C.I., Daling J.R., and Malone K.E. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1008-1011
4. Chia K.S., Reilly M., Tan C.S., Lee J., Pawitan Y., Adami H.O., Hall P., and Mow B. Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int. J. Cancer 113 (2005) 302-306
5. Sweeney C., Blair C.K., Anderson K.E., Lazovich D., and Folsom A.R. Risk factors for breast cancer in elderly women. Am. J. Epidemiol. 160 (2004) 868-875
6. Cleary M.P., and Maihle N.J. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc. Soc. Exp. Biol. Med. 216 (1997) 28-43
7. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 (2003) 1625-1638
8. Althuis M.D., Fergenbaum J.H., Garcia-Closas M., Brinton L.A., Madigan M.P., and Sherman M.E. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1558-1568
9. Purohit A., and Reed M.J. Regulation of estrogen synthesis in postmenopausal women. Steroids 67 (2002) 979-983
10. Siiteri P.K. Adipose tissue as a source of hormones. Am. J. Clin. Nutr. 45 (1987) 277-282
11. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 (2004) 2548-2556
12. Boyapati S.M., Shu X.O., Gao Y.T., Dai Q., Yu H., Cheng J.R., Jin F., and Zheng W. Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women. Cancer Causes Control 15 (2004) 305-311
13. Yee D. The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res. Treat. 32 (1994) 85-95
14. Toniolo P., Bruning P.F., Akhmedkhanov A., Bonfrer J.M., Koenig K.L., Lukanova A., Shore R.E., and Zeleniuch-Jacquotte A. Serum insulin-like growth factor-I and breast cancer. Int. J. Cancer 88 (2000) 828-832
15. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
16. Del Giudice M.E., Fantus I.G., Ezzat S., McKeown-Eyssen G., Page D., and Goodwin P.J. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res. Treat. 47 (1998) 111-120
17. Hankinson S.E., and Schernhammer E.S. Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast Dis. 17 (2003) 27-40
18. Shi R., Yu H., McLarty J., and Glass J. IGF-I and breast cancer: a meta-analysis. Int. J. Cancer 111 (2004) 418-423
19. Pekonen F., Partanen S., Mäkinen T., and Rutanen E.-M. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res. 48 (1988) 1343-1347
20. Peyrat J.-P., Bonneterre J., Beuscart R., Djiane J., and Demaille A. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res. 48 (1988) 6429-6433
21. Laud K., Gourdou I., Pessemesse L., Peyrat J.P., and Djiane J. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol. Cell Endocrinol. 188 (2002) 219-226
22. Hu X., Juneja S.C., Maihle N.J., and Cleary M.P. Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J. Natl. Cancer Inst. 94 (2002) 1704-1711
23. Dieudonne M.N., Machinal-Quelin F., Serazin-Leroy V., Leneveu M.C., Pecquery R., and Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 293 (2002) 622-628
24. Cleary M.P., Phillips F.C., Getzin S.C., Jacobson T.L., Jacobson M.K., Christensen T.A., Juneja S.C., Grande J.P., and Maihle N.J. Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res. Treat. 77 (2003) 205-215
25. Halter S.A., Dempsey P., Matsui Y., Stokes M.K., Graves-Deal R., Hogan B.L., and Coffey R.J. Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations. Am. J. Pathol. 140 (1992) 1131-1146
26. Cleary M.P., Juneja S.C., Phillips F.C., Hu X., Grande J.P., and Maihle N.J. Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp. Biol. Med. (Maywood) 229 (2004) 182-193
27. Cleary M.P., Grande J.P., and Maihle N.J. Effect of high fat diet on body weight and mammary tumor latency in MMTV-TGF-alpha mice. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 956-962
28. Cleary M.P., Grande J.P., Juneja S.C., and Maihle N.J. Diet-induced obesity and mammary tumor development in MMTV-neu female mice. Nutr. Cancer 50 (2004) 174-180
29. Xin X., Storlien L.H., and Huang X.F. Hypothalamic c-fos-like immunoreactivity in high-fat diet-induced obese and resistant mice. Brain Res. Bull. 52 (2000) 235-242
30. Salomons G.S., Brady H.J., Verwijs-Janssen M., Van Den Berg J.D., Hart A.A., Van Den Berg H., Behrendt H., Hahlen K., and Smets L.A. The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int. J. Cancer 71 (1997) 959-965
31. Baliga M.S., Meleth S., and Katiyar S.K. Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin. Cancer Res. 11 (2005) 1918-1927
32. Stephenson G.D., and Rose D.P. Breast cancer and obesity: an update. Nutr. Cancer 45 (2003) 1-16
33. Kaaks R. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found. Symp. 262 (2004) 247-260 discussion 260-268
34. O'Connor R., Fennelly C., and Krause D. Regulation of survival signals from the insulin-like growth factor-I receptor. Biochem. Soc. Trans. 28 (2000) 47-51
35. Gonzalez M.J., Schemmel R.A., Dugan Jr. L., Gray J.I., and Welsch C.W. Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids 28 (1993) 827-832
36. Welsch C.W., Welsch M.A., Huelskamp L.J., Gonzalez M.J., and Vanderploeg L.C. Influence of dietary fat on growth of MDA-MB-231 human breast carcinoma maintained in female athymic nude mice. Int. J. Oncol. 6 (1995) 55-64
37. Gonzalez M.J., Schemmel R.A., Gray J.I., Dugan Jr. L., Sheffield L.G., and Welsch C.W. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis 12 (1991) 1231-1235
38. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 (1993) 1939-1951
39. Castracane V.D., Kraemer R.R., Franken M.A., Kraemer G.R., and Gimpel T. Serum leptin concentration in women: effect of age, obesity, and estrogen administration. Fertil. Steril. 70 (1998) 472-477
40. Mavri A., Stegnar M., and Sabovic M. Do baseline serum leptin levels predict weight regain after dieting in obese women?. Diabetes Obes. Metab. 3 (2001) 293-296
41. Coskun U., Gunel N., Toruner F.B., Sancak B., Onuk E., Bayram O., Cengiz O., Yilmaz E., Elbeg S., and Ozkan S. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma 50 (2003) 41-46
42. Mantzoros C., Petridou E., Dessypris N., Chavelas C., Dalamaga M., Alexe D.M., Papadiamantis Y., Markopoulos C., Spanos E., Chrousos G., and Trichopoulos D. Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab. 89 (2004) 1102-1107
43. Furberg A.S., Jasienska G., Bjurstam N., Torjesen P.A., Emaus A., Lipson S.F., Ellison P.T., and Thune I. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 33-40
44. Tessitore L., Vizio B., Jenkins O., De Stefano I., Ritossa C., Argiles J.M., Benedetto C., and Mussa A. Leptin expression in colorectal and breast cancer patients. Int. J. Mol. Med. 5 (2000) 421-426
45. Petridou E., Papadiamantis Y., Markopoulos C., Spanos E., Dessypris N., and Trichopoulos D. Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11 (2000) 383-388
46. Han C., Zhang H.T., Du L., Liu X., Jing J., Zhao X., Yang X., and Tian B. Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine 26 (2005) 19-24
47. Mantzoros C.S., Bolhke K., Moschos S., and Cramer D.W. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int. J. Cancer 80 (1999) 523-526
48. Ishikawa M., Kitayama J., and Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin. Cancer Res. 10 (2004) 4325-4331
49. Miyoshi Y., Funahashi T., Tanaka S., Taguchi T., Tamaki Y., Shimomura I., and Noguchi S. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int. J. Cancer 118 (2006) 1414-1419
50. Snoussi K., Strosberg A.D., Bouaouina N., Ben Ahmed S., Helal A.N., and Chouchane L. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 6 (2006) 38